Latest News about RGNX

Recent news which mentions RGNX

< Previous 1 2 3 4 5 Next >

Earnings Scheduled For March 13, 2025

March 13, 2025

Regenxbio's Gene Therapy Outlook Dims As Rival Treatments Gain Ground, Goldman Sachs Warns

February 11, 2025

A Glimpse Into The Expert Outlook On Regenxbio Through 7 Analysts

February 11, 2025

Regenxbio Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)

January 15, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

January 14, 2025

Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket

January 14, 2025

Where Regenxbio Stands With Analysts

December 11, 2024

What's Going On With REGENXBIO Shares Monday?

November 18, 2024

Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday

November 18, 2024

5 Analysts Have This To Say About Regenxbio

November 15, 2024

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

November 06, 2024

What 4 Analyst Ratings Have To Say About Regenxbio

October 10, 2024

Assessing Regenxbio: Insights From 5 Financial Analysts

September 04, 2024

7 Biotech Stocks to Buy for Their Game-Changing Potential

August 08, 2024

Where Regenxbio Stands With Analysts

August 05, 2024

Why Is Clearside Biomedical Stock Gaining Today?

June 25, 2024

7 Biotech Stocks to Buy on the Dip: June 2024

June 24, 2024

FDA Approves Expanded Use For Sarepta's Rare Muscular Dystrophy Gene Therapy

June 21, 2024

Goldman Sachs Optimistic About Regenxbio's Gene Therapy Pipeline, Sees Over 160% Upside

June 07, 2024

Assessing Regenxbio: Insights From 4 Financial Analysts

June 07, 2024

Evaluating Regenxbio: Insights From 9 Financial Analysts

May 15, 2024

RGNX Stock Earnings: Regenxbio Misses EPS, Misses Revenue for Q1 2024

May 08, 2024

Where Regenxbio Stands With Analysts

April 12, 2024

12 Health Care Stocks Moving In Monday's After-Market Session

March 25, 2024

Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?

March 13, 2024

This Gene Therapy Player Duchenne Data Is Impressive, Analyst Upgrades REGENXBIO

March 08, 2024

Beyond The Numbers: 4 Analysts Discuss Regenxbio Stock

March 06, 2024

REGENXBIO's Muscle Wasting Disorder Drug Shows Strength, Improved Motor Function, Stock Soars

March 05, 2024

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

March 05, 2024

Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session

March 01, 2024

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.